- Home
- Solutions
- By Disease
- Systemic Mitochondrial Disease
- Alpers Disease
- Barth Syndrome
- Carnitine Deficiency
- Creatine Deficiency Syndromes
- Co-Enzyme Q10 Deficience
- Friedreich’s Ataxia
- Kearns-Sayre Syndrome
- Lactic Acidosis
- Leigh Syndrome
- Mitochondrial DNA Depletion Syndrome
- MELAS Syndrome
- Multiple Mitochondrial Dysfunction Syndrome
- Short-Chain Acyl-CoA Dehydrogenase Deficiency
- Thymidine Kinase 2 Deficiency
- Mitochondrial Neurogastrointestinal Encephalopathy
- Organ-specific Mitochondrial Diseases
- Systemic Mitochondrial Disease
- By Applications
- Mitochondrial Disease Diagnostics Service
- Therapeutics Development Services for Mitochondrial Diseases
- Mitochondrial Disease Target Development & Identification Service
- Mitochondrial Disease Model Development Service
- Drug Development Service for Mitochondrial Diseases
- In Vitro Mitochondrial Analysis Service
- In Vivo Mitochondrial Fission and Fusion Analysis
- By Molecular Type
- By Disease
- Products
- Mitochondrial Isolation Reagents & Kits
- Mitochondrial Staining Reagents & Kits
- Mitochondrial Disease Diagnostic Reagents & Kits
- Biochemical Inhibitors & Activators
- Mitochondrial Specific Antibodies
- Mitochondrial Recombinant Proteins
- Mitochondria Related Peptides
- Natural Products Targeting Mitochondria
- Resource
- About Us
- Contact Us
- Careers
Products
Online Inquiry
Biochemical Inhibitors & Activators
Mitochondria-targeting biochemical inhibitors and activators play a critical role in mitochondrial research and are essential in the study of mitochondrial diseases. By precisely modulating specific enzymes and pathways within mitochondria, researchers can dissect the complex mechanisms underlying mitochondrial dysfunctions, which contribute to a wide range of diseases. This approach is fundamental to the discovery and development of novel therapeutic strategies.
Optional Biochemical Inhibitors & Activators
Protheragen is committed to advancing mitochondrial disease research by providing a comprehensive portfolio of mitochondrial biochemical inhibitors and activators. Our collection comprises a wide range of products targeting key mitochondrial functions, such as oxidative phosphorylation inhibitors, mitochondrial dynamics modulators, metabolic modulators, permeability transition pore modulators, ion channel modulators, antioxidants, and modulators of apoptosis and autophagy. Each product undergoes rigorous quality control to ensure high reliability and reproducibility, making them ideal for experiments that demand precision and consistency.
In addition to our established offerings, we provide customized development services tailored to your specific research needs. Our expert team offers solutions such as custom synthesis of inhibitors or activators, assay development, and protocol optimization. Feel free to contact us at any time if you need more specific details regarding our services and products.
Browse our list of biochemical inhibitors & activators
Product Name | Cat.No. | Antibody Type | Price | Datasheet |
---|---|---|---|---|
Acetazolamide | BIAOS-2505-CXX-4 | Inquiry |
![]() |
|
AG-18 | BIAOS-2505-CXX-5 | Inquiry |
![]() |
|
AG-494 | BIAOS-2505-CXX-6 | Inquiry |
![]() |
|
Auraptene | BIAOS-2505-CXX-7 | Inquiry |
![]() |
|
BRL 54443 | BIAOS-2505-CXX-8 | Inquiry |
![]() |
|
Buspirone hydrochloride | BIAOS-2505-CXX-9 | Inquiry |
![]() |
|
BVT 948 | BIAOS-2505-CXX-10 | Inquiry |
![]() |
|
Canagliflozin | BIAOS-2505-CXX-11 | Inquiry |
![]() |
|
CGP 57380 | BIAOS-2505-CXX-12 | Inquiry |
![]() |
|
CGP 7930 | BIAOS-2505-CXX-13 | Inquiry |
![]() |
For research use only, not for clinical use.